BR112012021624A2 - uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor. - Google Patents

uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor.

Info

Publication number
BR112012021624A2
BR112012021624A2 BR112012021624A BR112012021624A BR112012021624A2 BR 112012021624 A2 BR112012021624 A2 BR 112012021624A2 BR 112012021624 A BR112012021624 A BR 112012021624A BR 112012021624 A BR112012021624 A BR 112012021624A BR 112012021624 A2 BR112012021624 A2 BR 112012021624A2
Authority
BR
Brazil
Prior art keywords
cancer
mammal
preventing
treating
antitumor
Prior art date
Application number
BR112012021624A
Other languages
English (en)
Portuguese (pt)
Inventor
Ling Foo Hooi
Oon Chuah Li
Banu Alitheen Noorjahan
Absul Rahim Raha
Chwen Loh Tech
Original Assignee
Univ Putra Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra Malaysia filed Critical Univ Putra Malaysia
Publication of BR112012021624A2 publication Critical patent/BR112012021624A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112012021624A 2010-11-29 2010-11-29 uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor. BR112012021624A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MY2010/000307 WO2012074351A1 (en) 2010-11-29 2010-11-29 Tumour cytotoxic agent and methods thereof

Publications (1)

Publication Number Publication Date
BR112012021624A2 true BR112012021624A2 (pt) 2017-02-07

Family

ID=46172112

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012021624A BR112012021624A2 (pt) 2010-11-29 2010-11-29 uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor.

Country Status (7)

Country Link
US (2) US9480721B2 (enExample)
EP (1) EP2646042A4 (enExample)
JP (1) JP5913353B2 (enExample)
KR (1) KR101747815B1 (enExample)
BR (1) BR112012021624A2 (enExample)
SG (1) SG183544A1 (enExample)
WO (1) WO2012074351A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX387817B (es) 2015-01-23 2025-03-11 Univ Temple Uso de acidos grasos de cadena corta en prevencion de cancer.
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
WO2021172900A1 (ko) 2020-02-26 2021-09-02 주식회사 지아이바이옴 락토바실러스 헬베티쿠스 균주 및 이를 포함하는 염증성 질환의 예방 또는 치료용 조성물
WO2022068924A1 (zh) * 2020-09-30 2022-04-07 成都夸常奥普医疗科技有限公司 益生菌组分的应用以及包含益生菌组分的药物组合物
CN117042786A (zh) * 2021-03-22 2023-11-10 Gi生物群系公司 植物乳杆菌gb104菌株及包含其的用于预防或治疗癌症的组合物
KR102630915B1 (ko) * 2022-02-10 2024-02-01 주식회사 지아이바이옴 락토바실러스 플란타룸 균주 및 항암제를 포함하는 병용 요법을 이용한 암 예방 또는 치료용 조성물
CN116144530B (zh) * 2022-11-17 2023-07-21 朗恒科技集团有限公司 一株植物乳杆菌ay01及其应用
KR20240123764A (ko) * 2023-02-06 2024-08-14 주식회사 지아이바이옴 락토바실러스 플란타룸 균주 및 면역세포의 병용 요법을 이용한 암 예방 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009093447A1 (ja) * 2008-01-22 2009-07-30 National University Corporation Asahikawa Medical College 消化器癌に対する抗腫瘍剤
JP5504485B2 (ja) * 2008-12-04 2014-05-28 国立大学法人広島大学 Ｉｌ−８阻害剤およびその製造方法
AU2009344224B2 (en) 2009-04-09 2015-08-20 Universiti Putra Malaysia (Upm) Monogastric animal feed
MY158907A (en) * 2009-08-10 2016-11-30 Univ Putra Malaysia Upm Metabolites in animal feed

Also Published As

Publication number Publication date
AU2010365001A1 (en) 2012-08-30
JP5913353B2 (ja) 2016-04-27
WO2012074351A1 (en) 2012-06-07
US20130323215A1 (en) 2013-12-05
KR20130132398A (ko) 2013-12-04
SG183544A1 (en) 2012-10-30
EP2646042A4 (en) 2014-07-23
KR101747815B1 (ko) 2017-06-15
JP2014500263A (ja) 2014-01-09
EP2646042A1 (en) 2013-10-09
US20160030492A1 (en) 2016-02-04
US9480721B2 (en) 2016-11-01

Similar Documents

Publication Publication Date Title
BR112012021624A2 (pt) uso de cepas de bactérias de um ácido láctico para evitar ou tratar um tumor, composição para tratar ou previnir câncer, método para facilitar apoptose de células de câncer em um mamífero, kit para previnir ou tratar um câncer em um mamífero, e gêneros alimentícios para antitumor.
NZ700759A (en) Combination therapy for treating cancer
PH12019500521A1 (en) Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
MX2021013830A (es) Inhibidores de ezh2 para tratar linfomas.
MX2019008428A (es) Inhibidores de glucosilceramida sintasa.
MX2016007351A (es) Terapia de combinacion para tratar cancer.
MX2013008212A (es) Derivados de 7-azaindol.
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
BR112016014481A2 (pt) tratamento de câncer utilizando combinações de inibidores de erk e raf
MY162514A (en) Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
MX381582B (es) Terapia de combinacion para el tratamiento de neoplasias malignas.
BR112013002012A2 (pt) métodos e composições para terapia de câncer de fígado
MY161237A (en) Combination therapy comprising a cdk4/6 inhibitor and a p13k inhibitor for use in the treatment of cancer
PH12014501639B1 (en) Pharmaceutical compositions and methods
GB201111485D0 (en) Drug composition and its use in therapy
PH12012501680A1 (en) Compositions and methods for the diagnosis and treatment of tumor
IL207310A0 (en) Vaccine compositions
PH12014500859A1 (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
AU2013357030A8 (en) Chlorin derivative useful in photodynamic therapy and diagnosis
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
PH12013501163A1 (en) Compositions comprising a p13k inhibitor and a mek inhibitor and their use for treating cancer
PH12012501963A1 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2015035410A8 (en) Cancer therapy
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2449 DE 12/12/2017 POR TER SIDO INDEVIDA.

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2475 DE 12/06/2018 POR TER SIDO INDEVIDA.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30/10/2018.